July 02, 2025 FDA Approves Ready-to-Infuse Vancomycin Tyzavan is the first FDA-approved vancomycin formulation available at room temperature that requires no compounding, thawing, or dilution, enabling faster treatment in time-critical infections like sepsis. Conexiant
July 01, 2025 Director of Clinical Resources Group Announces Report on Ocular Risks of Glucagon-Like Peptide-1 Agonists Optometric Management
July 01, 2025 Director of Clinical Resources Group Announces Report on Ocular Risks of Glucagon-Like Peptide-1 Agonists Optometric Management
July 01, 2025 When the Hat No Longer Fits: Realigning Roles for a Healthier Practice Optometric Management
January 06, 2023 Year in Review: Pacific Dental Services Celebrates 2022 Milestones and Achievements Inside Dentistry